Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CODA MINERALS LTD Director's Dealing 2023

Dec 5, 2023

64682_rns_2023-12-05_1387bf7d-0ad2-4a33-a45a-488b32b2f310.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Coda Minerals Ltd ABN 49 625 763 957

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Christopher Stevens
Date of last notice 14 August 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Dr Catriona Fleur Stevens –spouse
Date of change 6 December 2023
No. of securities held prior to change Christopher Stevens
358,174 fully paid ordinary shares
Dr Catriona Fleur Stevens –spouse
226,030 fully paid ordinary shares
2,000,000 options, exercise price $0.2145
and expiring on 3 July 2024
34,416 2021 Performance Rights
314,402 2022 Performance Rights
Loutre Investments Pty Ltd **SMSF A/C> -director of trustee and
beneficiary of account
295,833 fully paid ordinary shares
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class Performance Rights - expiring 13
November 2023
Number acquired 4,246,705
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Nil. Issued pursuant to shareholder
approval obtained at the 2023 AGM held
on 10 November 2023.
No. of securities held after change Christopher Stevens
358,174 fully paid ordinary shares
Dr Catriona Fleur Stevens –spouse
226,030 fully paid ordinary shares
2,000,000 options, exercise price $0.2145
and expiring on 3 July 2024
34,416 2021 Performance Rights
314,402 2022 Performance Rights
4,246,705 Performance Rights (expiring 13
November 2028)
Loutre Investments Pty Ltd **SMSF A/C> -director of trustee and
beneficiary of account
295,833 fully paid ordinary shares
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Issue of 823,727 CEO Service Rights and
3,422,978 CEO Performance Rights both
expiring on 13 November 2028 following
shareholder approval obtained at the 2023
AGM held on 10 November 2023.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade N/A to proceed during this period? If prior written clearance was provided, on what date was this N/A provided?

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3